21. A literature review of the patent application publications on cabotegravir – an HIV integrase strand transfer inhibitor. (3rd March 2020) Authors: Kovač, Lidija; Časar, Zdenko Journal: Expert opinion on therapeutic patents Issue: Volume 30:Number 3(2020) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. A literature review of the patent publications on venetoclax – a selective Bcl-2 inhibitor: discovering the therapeutic potential of a novel chemotherapeutic agent. (3rd July 2019) Authors: Žigart, Nina; Časar, Zdenko Journal: Expert opinion on therapeutic patents Issue: Volume 29:Number 7(2019) Page Start: 487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. A patent and literature review of CDK12 inhibitors. (3rd October 2022) Authors: Tang, Ruijun; Liu, Jing; Li, Shuyao; Zhang, Junjie; Yu, Chunhong; Liu, Honglu; Chen, Fang; Lv, Lu; Zhang, Qian; Yuan, Kai; Shao, Hao Journal: Expert opinion on therapeutic patents Issue: Volume 32:Number 10(2022) Page Start: 1055 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. A patent review of adaptor associated kinase 1 (AAK1) inhibitors (2013-present). (3rd October 2021) Authors: Martinez-Gualda, Belén; Schols, Dominique; De Jonghe, Steven Journal: Expert opinion on therapeutic patents Issue: Volume 31:Number 10(2021) Page Start: 911 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. A patent review of adenosine A2B receptor antagonists (2016-present). (3rd June 2022) Authors: Francucci, Beatrice; Dal Ben, Diego; Lambertucci, Catia; Spinaci, Andrea; Volpini, Rosaria; Marucci, Gabriella; Buccioni, Michela Journal: Expert opinion on therapeutic patents Issue: Volume 32:Number 6(2022) Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. A patent review of aldosterone synthase inhibitors (2014-present). (2nd January 2022) Authors: Wu, Jun; Ding, Xiao; Tan, Xuefei Journal: Expert opinion on therapeutic patents Issue: Volume 32:Number 1(2022) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. A patent review of anticancer CDK2 inhibitors (2017–present). (3rd August 2022) Authors: Said, Mohamed A.; Abdelrahman, Mohamed A.; Abourehab, Mohammed A.S.; Fares, Mohamed; Eldehna, Wagdy M. Journal: Expert opinion on therapeutic patents Issue: Volume 32:Number 8(2022) Page Start: 885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. A patent review of anticancer glucocorticoid receptor modulators (2014-present). (3rd May 2020) Authors: Lucafò, Marianna; Franzin, Martina; Decorti, Giuliana; Stocco, Gabriele Journal: Expert opinion on therapeutic patents Issue: Volume 30:Number 5(2020) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. A patent review of apelin receptor (APJR) modulators (2014-2019). (2nd April 2020) Authors: Fischer, Conrad Journal: Expert opinion on therapeutic patents Issue: Volume 30:Number 4(2020) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. A patent review of arginine methyltransferase inhibitors (2010–2018). (1st February 2019) Authors: Li, Xiao; Wang, Chen; Jiang, Hao; Luo, Cheng Journal: Expert opinion on therapeutic patents Issue: Volume 29:Number 2(2019) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗